Bronchiolitis Obliterans Syndrome (BOS) Active Not Recruiting Phase 1 Trials for Pirfenidone (DB04951)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03315741The Safety and Tolerability of Pirfenidone for BOS After HCTTreatment